Remarkably, a cannabinoid receptor 2 agonist, JWH-015, inhibits M2 macrophage-induced epithelial-mesenchymal transition (EMT) in NSCLC cells by downregulating the EGFR signaling pathway (24). Here, EGFR is linked to non-small cell lung carcinoma.